PULSE GEN MODEL 101
Report
- Report Number
- 1644487-2006-00284
- Event Type
- Death
- Date Received
- August 11, 2006
- Date of Event
- June 13, 2006
- Report Date
- July 13, 2006
- Manufacturer
- CYBERONICS, INC.
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- OTHER
Narratives
TREATING PHYSICIAN INDICATED THAT, THE NCP SYSTEM WAS NOT RELATED TO THE CAUSE OF DEATH.
REPORTER INDICATED THAT VNS PATIENT HAD PASSED AWAY. TREATING PHYSICIAN INDICATED THAT THE CAUSE OF DEATH WAS SUDEP (SUDDEN UNEXPLAINED DEATH IN EPILEPSY). IT WAS REPORTED THAT THE PT WAS FOUND DEAD IN BED IN THE MORNING WITH NO EVIDENCE OF SEIZURE. TREATING PHYSICIAN INDICATED THAT THE PATIENT EXPERIENCED A >50% REDUCTION IN SEIZURE ACTIVITY WITH THE VNS THERAPY AND WAS RECEIVING THERAPY AT THE TIME OF DEATH. SYSTEM DIAGNOSTICS TESTING PERFORMED AT OFFICE VISIT APPROX THREE MONTHS PRIOR TO DEATH WAS WITHIN NORMAL LIMITS, INDICATING PROPER DEVICE FUNCTION AT THAT TIME. TREATING PHYSICIAN INDICATED THAT THE NCP SYSTEM WAS NOT RELATED TO THE CAUSE OF DEATH. IT WAS REPORTED THAT THE NCP SYSTEM WAS NOT EXPLANTED AND WILL THEREFORE NOT BE RETURNED TO MANUFACTURER FOR ANALYSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PULSE GEN MODEL 101 | LYJ | LYJ | CYBERONICS, INC. | 101 | 29648C |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 18 YR | Death | LAMOTRIGINE| MEDICATIONS AT TIME OF DEATH INCLUDE:| LEVETIRACETAM| BIPOL LEAD MODEL 300-20| IMPLANT DATE: |